Regenxbio (RGNX) Interest Expenses (2014 - 2025)

Regenxbio's Interest Expenses history runs 7 years deep, the most recent figure standing at $12.3 million for Q4 2025.

• In Q4 2025, Interest Expenses rose 30.36% year-over-year to $12.3 million; the TTM figure through Dec 2025 stood at $45.0 million (up 255.54% YoY), while the FY2025 annual figure was $45.0 million, up 255.54% from the prior year.
• Interest Expenses was $12.3 million for Q4 2025 at Regenxbio, down from $13.2 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $13.2 million in Q3 2025 to a low of $449000.0 in Q2 2024.
• Historically, Interest Expenses has averaged $5.7 million across 5 years, with a median of $6.2 million in 2021.
• The sharpest annual moves came in 2023 and 2025: Interest Expenses plunged 83.67% in 2023, then soared 2348.33% in 2025.
• A 5-year view of Interest Expenses shows it stood at $6.5 million in 2021, then tumbled by 33.69% to $4.3 million in 2022, then sank by 68.38% to $1.4 million in 2023, then jumped by 590.9% to $9.4 million in 2024, then jumped by 30.36% to $12.3 million in 2025.
• The last three Interest Expenses figures came in at $12.3 million (Q4 2025), $13.2 million (Q3 2025), and $11.0 million (Q2 2025), per Business Quant data.